Skip to main content
Lung Cancer, FDA Updates
Opdivo-Yervoy First Immunotherapy Combo Approved for First-Line Therapy of Patients with Metastatic NSCLC
Read More
FDA Updates
Tabrecta First FDA-Approved Targeted Therapy for Metastatic NSCLC and MET Exon 14 Skipping
Read More
FDA Updates
Retevmo First Therapy Approved for 3 Types of Cancers with RET Mutations
Read More
Online Only
COVID-19
Innovation Among Pharmaceutical Manufacturers During COVID-19
Read More
COVID-19
Impact of COVID-19 on Oncology Pharmacy
Read More
COVID-19
COVID-19: Challenges Facing Community Cancer Care Providers
Read More
Online Only
COVID-19
Comprehensive Cancer Care Centers and Integrated Delivery Systems
Read More
Online Only
Facing New Challenges in the Delivery of Cancer Care
Read More
Online Only
Patient Advocacy During the COVID-19 Crisis
Read More
FDA Updates
FDA Approves Darzalex Faspro as Subcutaneous Formulation for All Patients with Multiple Myeloma
Read More
Page 134 of 196
Results 1331 - 1340 of 1954